Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Flebogammadif“
Suchtreffer
Begriffe & Kennungen
Flebogamma DIF (previously Flebogammadif)
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.1 Therapeutic indications · 1
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.1 Therapeutic indications · 2
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 Contraindications · 1
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 Contraindications · 2
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Hereditary fructose intolerance (see section 4.4). In babies and young children (aged 0 - 2 years) hereditary
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Hereditary fructose intolerance (see section 4.4). In babies and young children (aged 0 - 2 years) hereditary
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Hypersensitivity to the active substance (human immunoglobulins) or to any of the excipients (see sections 4.4
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Hypersensitivity to the active substance (human immunoglobulins) or to any of the excipients (see sections 4.4
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Patients with selective IgA deficiency who developed antibodies to IgA, as administering an IgA-containing pro
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Patients with selective IgA deficiency who developed antibodies to IgA, as administering an IgA-containing pro
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.4 Special warnings and precautions for use · 2
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of l
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of l
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · It is expected that the same interactions than those mentioned for the adults may be presented by the paediatr
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · It is expected that the same interactions than those mentioned for the adults may be presented by the paediatr
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · Live attenuated virus vaccines
Eintrag öffnen